Frontiers in Oncology (Aug 2022)

FOXM1 is regulated by DEPDC1 to facilitate development and metastasis of oral squamous cell carcinoma

  • Jing Qiu,
  • Yongping Tang,
  • Lan Liu,
  • Jiangbo Yu,
  • Zhenggang Chen,
  • Hao Chen,
  • Hao Chen,
  • Rongtao Yuan

DOI
https://doi.org/10.3389/fonc.2022.815998
Journal volume & issue
Vol. 12

Abstract

Read online

The Disheveled, EGL-10, Pleckstrin domain containing 1 (DEPDC1) is a new oncogene that has recently been described. The mechanisms and functions of its expression are yet to be determined in oral squamous cell carcinoma (OSCC). In the present study, the impact of DEPDC1 on the growth and development of OSCC was investigated using animal models, cell lines and human tissue samples. Elevated DEPDC1 expression within cancer cell lines and human OSCC has been identified. Mechanistic examination showed that restored DEPDC1 expression in vivo and in vitro stimulated OSCC tumour development. In addition, FOXM1 interacts with DEPDC1 as indicated by co-immunoprecipitation and immunofluorescence testing. Functionally, DEPDC1 facilitated Wnt/β-catenin signal transduction and β-catenin protein nuclear expression. In summary, the DEPDC1, interacting with FOXM1 via Wnt/β-catenin signaling, the closely regulated OSCC pathogenesis, suggesting that targeting the novel DEPDC1/FOXM1/β-catenin complex is an essential OSCC therapeutic approach.

Keywords